The South Korean government will convene a 300-member citizen panel to explore ways to revive regional and essential healthcare. The panel will report its findings to the Medical Innovation Committee after a public deliberation process lasting one to two months. The Medical Innovation Committee is an organization established under the Prime Minister's Office to promote institutional improvement and innovation in the healthcare sector through public participation.
The government said it held the 5th Medical Innovation Committee meeting Tuesday morning at the Government Complex in Seoul, chaired by Committee Chairman Chung Ki-hyun, to discuss the proposed agenda for the citizen panel's public deliberation. The committee selected "public deliberation to revive regional and essential healthcare" as the first agenda item for citizens to debate. The move follows a decision at the previous meeting that agenda items of high public interest would be subject to citizen panel deliberation to produce recommendations.
On the healthcare utilization side, the citizen panel will discuss the public need for regional healthcare, the minimum and expected levels of regional healthcare required for residents who choose to live in the regions, and measures to encourage the use of regional healthcare. The Ministry of Health and Welfare believes that amid the crisis of regional extinction, it can assess the impact of regional medical services on the living environment in those areas, while citizens can directly present the problems they experience and the policies they need.
The citizen panel will also discuss measures to efficiently supply essential healthcare within regions. Topics will include development plans prioritizing public hospitals to foster regional healthcare and their efficiency, standards for good hospitals within regions, and other measures needed to provide stable regional healthcare. The panel will also deliberate on the authority and responsibilities of central and local governments, including strengthening local governments' decision-making power over the allocation of medical resources within their regions.
The committee will hold a citizen panel steering committee meeting on the 11th of next month to establish specific operational plans, including the deliberation program, and to recruit and form the 300-member citizen panel. After a public deliberation process lasting approximately one to two months, the results will be reported to the committee.
Asked at the briefing how binding the citizen panel's deliberation results would be, Chung said, "Even if citizens' demands may lack some coherence from an expert's perspective, they must be reflected in the broader framework and help guide policy direction." He added, "Fundamentally, citizens' opinions must be reflected."
